AEON Biopharma, Inc. recently announced its financial results for the fiscal year that ended on December 31, 2023. The company's earnings details have been released in a press release, which is included as Exhibit 99.1 in the report. AEON's common stock, with a par value of $0.0001 per share, is registered with the trading symbol AEON, and its warrants to purchase common stock trade under AEON WS on the NYSE American.
Proper Names Mentioned: - AEON Biopharma, Inc. - NYSE American - Marc Forth (Chief Executive Officer)